By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.


Four Essentials from CTFN This Week

Industrial gas giants Linde and Praxair are in discussions with Latin American regulators for the sale of the overlapping assets that will need to be divested to gain clearance for their planned merger. More here … As the pleading cycle for the Tribune/Sinclair merger comes to a close, it appears unlikely the Federal Communications Commission … Read Morefeatured

Day 5: Akorn v. Fresenius Trial

Day five of the Akorn trial began with Stephan Sturm, CEO and chairman of Fresenius, called to the witness stand and testifying about his “disappointment” at thefeatured

Judge to Weigh Akorn Violations

Fresenius will have one more day to convince a Delaware judge that data integrity violations at Akorn are severe enough to allow the German healthcare giant to back outfeatured

Akorn v. Fresenius: Notes from Day Four of the Trial

Corrected for witness name in updates beginning 12:29pm … Day 4 of the trial began with the lawyer for Fresenius continuing a heated cross-examination of the attorney who conducted Akorn’s internal investigation into the fraudulentfeatured

Day 3: Akorn v. Fresenius

Day three of the Akorn v. Fresenius trial began with the lead attorney for Fresenius cross-examining Akorn CEO Raj Rai about whether Akorn investigatingfeatured

Akorn v. Fresenius Trial: Day 2 Updates

Day two of the Akorn v. Fresenius trial began with a Fresenius attorney working to impeach Monday’s testimony of a compliance expert who testified on behalf of Akorn thatfeatured

Updates from the Akorn v. Fresenius Trial

A senior executive from Akorn downplayed its data integrity dispute with federal regulators this morning during the first day of a trial over Fresenius’ attempt to terminate itsfeatured

Updated: Judge Broadens Document Production in Akorn/Fresenius Dispute

Updated and Revised May 23, at 9:05am EDT: A Delaware judge dealt Akorn a setback May 22 in its efforts to preserve its $4.3 billion merger with Fresenius by ordering the Illinois-based generics maker to providefeatured

Akorn Executives Followed Kapoor from Troubled Predecessor

In August 1981, Dr. John Kapoor, presently the largest shareholder of Akorn and former CEO and chairman of the board, led a group that acquired Lyphomed from Stone Containerfeatured

Three Essentials from CTFN This Week

A number of competitors of industrial gas giants Linde and Praxair have expressed interest in acquiring the overlapping assets that the parties are likely to divest to gain antitrust approval for the planned merger, sources familiar with the situation told CTFN. More here … Fresenius announced on February 26 that it was “conducting an independent … Read Morefeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.